itulau_fanua

3415-08-5 L-Tyr-NCA

3415-08-5 L-Tyr-NCA

Fa'amatalaga Puupuu:

Fa'aaliga Pa'epa'e ile Pa'epa'e tioata po'o le pauta tioata
MF C10H9NO4
MW 207.18
Mama 98+


Fa'amatalaga Oloa

Tulaga o felauaiga & auala fautuaina o felauaiga:
i luga o le ea, i le sami poʻo le faʻaalia

Tulaga teuina:
nert atemosifia, Teu i totonu o le pusaaisa, i lalo -20°C

Fa'atauga La'ititi:
Fa'atalanoaga

Fa'ailoga:
COA, HPLC, GC, HNMR, Suʻega, Suavai (KF), TLC avanoa

D-Lys(tfa)-NCA (2)

Synonyms

Tyrosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S) -4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

totonu afifiina

E masani ona fa'aaogaina e fa'apipi'i ai le pauta.Ma e mafai ona latou puipuia le susulu o le la ma le vai mai le leaga.

Fa'amau totonu 2
Fa'apipi'i totonu 1
Fa'apipi'i totonu 3

afifiina i fafo

O le pusa malo e mafai ona puipuia au oloa mai le paʻu ma susu.

Fa'apipi'i fafo 3
Fa'apipi'i fafo 2
Fa'apipi'i fafo 1

Talosaga

3415-08-5 L-Tyr-NCA o se tasi o vaeluaga ole Glatiramer Acetate.

Glatiramer Acetate o se vailaʻau peptide saunia faʻapipiʻiina e fa amino acids: glutamic acid, alanine, tyrosine, ma le lysine.O lona faʻaaogaina muamua o loʻo taoto i le togafitiga o le Multiple Sclerosis (MS), o se faʻamaʻi faʻamaʻi, inflammatory, demyelinating faʻamaʻi e aʻafia ai le fatugalemu o le tino.E ala i le faʻaogaina o le "faʻafefeteina," Glatiramer Acetate faʻaaogaina immunomodulatory ma anti-inflammatory aʻafiaga i MS, faʻateleina le maualuga o le faiʻai e maua mai le neurotrophic factor (BDNF), faʻaitiitia le faʻaleagaina o le mumu, ma faʻalauteleina le tuputupu aʻe o axons ma myelin sheaths.

I le lalolagi atoa, ua maua e Glatiramer Acetate le faʻaaogaina lautele.Mo se faʻataʻitaʻiga, i le Iunaite Setete, o loʻo maketiina i lalo o le igoa Copaxone ma ua faʻamaonia e le Food and Drug Administration (FDA) mo togafitiga o le Multiple Sclerosis.I atunuu i Sisifo o loʻo iai le maualuga o le MS, o lona aoga ma le faʻatagaina ua lauiloa lautele.

I Saina, ia Iuni 28, 2023, "Glatiramer Acetate Injection" na maua aloaia le faʻatagaga mai le National Medical Products Administration (NMPA) mo le togafitia o tagata matutua maʻi ma le toe faʻafoʻiina o le tele o le Sclerosis (MS), e aofia ai maʻi faʻamaʻi faʻamaʻi, toe faʻafoʻiina. MS, ma MS fa'agasolo lona lua malosi.

oloa fa'atatau

L-Gly-NCA L-Ala-NCA D-Ala-NCA L-Val-NCA
D-Leu-NCA DL-leu-NCA L-Phe-NCA D-Tyr-NCA
L-Tyr(bzl)-NCA L-Glu(Obzl)-NCA D-Asp(OBzl)-NCA L-Lys(tfa)-NCA
L-Lys(Cbz)-NCA D-Lys(Cbz)-NCA Sar-NCA

Fa'asilisili

1. R&D auaunaga avanoa
2. ISO faʻamaonia le gaosiga, faʻamaonia lelei
3.O se vasega atoa o auaunaga tulitatao i le taimi o le gaosiga
4.High tau aoga
5.Quality pepa fa'amaonia e tu'uina atu ile talosaga a le tagata fa'atau
6.Great auaunaga faʻatau, tausia vavalalata vavalalata ma tagata faʻatau
7.Full punaoa e fesoasoani e faʻaitiitia tau o felauaiga
8. Free faʻataʻitaʻiga ofo atu e siaki le lelei aʻo leʻi faia soʻo se totogi
9. Totogi taimi feutagai
10. Assit tagata faʻatau e faʻatautaia mataupu i Saina


  • Muamua:
  • Sosoo ai:

  • Tusi lau savali iinei ma lafo mai ia i matou